Novartis’ Entresto is on course to become the first drug to be approved in the US for a form of heart failure that is notoriously hard to treat effectively, despite missing the mark in a phase 3 ...
But the drug is entering an increasingly competitive market, where Novartis and AstraZeneca are vying for supremacy. Entresto (sacubitril+valsartan) was FDA-approved in patients with reduced ...
Cyclosporine-drug interactions in adult transplant patients and the impact of age were studied. The medical records of transplant patients receiving cyclosporine therapy were identified.
Since 2022, it has been the cause of major epidemics spreading outside endemic ... Drug May Counteract Muscle Loss and Osteoporosis After Rapid Weight Loss Feb. 10, 2025 — Rapid weight loss ...
Histamine receptor, a typical G-protein-coupled receptor (GPCR), is important mediator of signalling and is responsible for regulation of human autoimmunity. Here, the authors report an artificial ...
Two Phoenix travelers' confusion over a cruise line's charges leads to On Your Side stepping in and sorting the matter out. A Mesa woman some expensive and fragile pieces of equipment and was ...
Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA (B.R.R., N.W.D.). Division of Cardiology, Department of Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback